506 related articles for article (PubMed ID: 15498797)
1. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
Ramos-Casals M; Tzioufas AG; Font J
Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
[TBL] [Abstract][Full Text] [Related]
2. Management of patients presenting with Sjogren's syndrome.
Venables PJ
Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
[TBL] [Abstract][Full Text] [Related]
3. [Sjögren's syndrome: a new approach to treatment].
Rossier V; Bart PA; Spertini F
Rev Med Suisse; 2012 Apr; 8(337):843-7. PubMed ID: 22594008
[TBL] [Abstract][Full Text] [Related]
4. Approaches to the treatment of Sjögren's syndrome.
Fox RI; Michelson P
J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjögren's Syndrome.
Mariette X; Criswell LA
N Engl J Med; 2018 Mar; 378(10):931-939. PubMed ID: 29514034
[No Abstract] [Full Text] [Related]
6. The management of Sjögren's syndrome.
Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
[TBL] [Abstract][Full Text] [Related]
7. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
Brito-Zerón P; Ramos-Casals M;
Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
[TBL] [Abstract][Full Text] [Related]
8. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
[TBL] [Abstract][Full Text] [Related]
9. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome: dental considerations.
Singh M; Palmer C; Papas AS
Dent Today; 2010 May; 29(5):64, 66-7; quiz 67. PubMed ID: 20506911
[No Abstract] [Full Text] [Related]
11. [Sjogren's syndrome].
Rasković S; Bogić M; Perić-Popadić A; Tomić-Spirić V
Srp Arh Celok Lek; 1997; 125(1-2):54-8. PubMed ID: 17974357
[TBL] [Abstract][Full Text] [Related]
12. Progress and regression within primary Sjögren's syndrome.
Manthorpe R; Bredberg A; Henriksson G; Larsson A
Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
[TBL] [Abstract][Full Text] [Related]
13. The therapy of Sjogren's syndrome: a review.
Coaccioli S; Giuliani M; Puxeddu A
Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
[TBL] [Abstract][Full Text] [Related]
14. What is Sjögren's syndrome and why is it important?
Talal N
J Rheumatol Suppl; 2000 Dec; 61():1-3. PubMed ID: 11128697
[No Abstract] [Full Text] [Related]
15. Primary Sjogren's syndrome: current and prospective therapies.
Thanou-Stavraki A; James JA
Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
[TBL] [Abstract][Full Text] [Related]
16. Articular manifestations of primary Sjögren's syndrome.
Castro-Poltronieri A; Alarcón-Segovia D
J Rheumatol; 1983 Jun; 10(3):485-8. PubMed ID: 6887174
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.
Choung BS; Yoo WH
Rheumatol Int; 2012 May; 32(5):1353-5. PubMed ID: 20237930
[TBL] [Abstract][Full Text] [Related]
18. [Sjögren's syndrome: diagnosis and systemic manifestations].
Hatron PY
Rev Prat; 2012 Feb; 62(2):221-4. PubMed ID: 22408869
[TBL] [Abstract][Full Text] [Related]
19. A combination of extraglandular manifestations of Sjögren's syndrome.
Cheah TE; Jasmin R; Sockalingam S
Int J Rheum Dis; 2012 Dec; 15(6):e156-8. PubMed ID: 23253245
[No Abstract] [Full Text] [Related]
20. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Al-Hashimi I
Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
